The company anticipates a notable rise in revenue for the second quarter of 2025, projecting a growth rate between 17.5% and 19.5% compared to the same period last year. This forecasted increase is based on reported figures and excludes the impacts of currency fluctuations and sales changes due to acquisitions and divestitures.
On an organic basis, which excludes the aforementioned factors, the company expects net sales growth to fall between 13% and 15%. This indicates a robust performance driven by the company's core operations.
In terms of earnings, the company estimates its earnings per share (EPS) on a GAAP basis to be between $0.45 and $0.47. Meanwhile, the adjusted EPS, which excludes specific charges, is projected to range from $0.71 to $0.73. This adjusted metric provides a clearer picture of the company's operational profitability, removing irregular expenses or income from the equation.
Wall Street Analysts Forecast
Based on the one-year price targets offered by 30 analysts, the average target price for Boston Scientific Corp (BSX, Financial) is $116.34 with a high estimate of $130.00 and a low estimate of $84.11. The average target implies an upside of 22.40% from the current price of $95.05. More detailed estimate data can be found on the Boston Scientific Corp (BSX) Forecast page.
Based on the consensus recommendation from 34 brokerage firms, Boston Scientific Corp's (BSX, Financial) average brokerage recommendation is currently 1.8, indicating "Outperform" status. The rating scale ranges from 1 to 5, where 1 signifies Strong Buy, and 5 denotes Sell.
Based on GuruFocus estimates, the estimated GF Value for Boston Scientific Corp (BSX, Financial) in one year is $76.94, suggesting a downside of 19.05% from the current price of $95.05. GF Value is GuruFocus' estimate of the fair value that the stock should be traded at. It is calculated based on the historical multiples the stock has traded at previously, as well as past business growth and the future estimates of the business' performance. More detailed data can be found on the Boston Scientific Corp (BSX) Summary page.
